| Literature DB >> 32505691 |
Felix Boschann1, Björn Fischer-Zirnsak2, Thomas F Wienker3, Manuel Holtgrewe4, Dominik Seelow5, Birgit Eichhorn6, Steffi Döhnert6, Raimund Fahsold6, Denise Horn7, Luitgard M Graul-Neumann8.
Abstract
Cohen syndrome (CS) is a rare, autosomal recessive disorder characterized by intellectual disability, postnatal microcephaly, facial abnormalities, abnormal truncal fat distribution, myopia, and pigmentary retinopathy. It is often considered an underdiagnosed condition, especially in children with developmental delay and intellectual disability. Here we report on four individuals from a large Jordanian family clinically diagnosed with CS. Using Trio Exome Sequencing (Trio-WES) and MLPA analyses we identified a maternally inherited novel intronic nucleotide substitution c.3446-23T > G leading to the activation of a cryptic splice site and a paternally inherited multi-exon deletion in VPS13B (previously termed COH1) in the index patient. Expression analysis showed a strong decrease of VPS13B mRNA levels and direct sequencing of cDNA confirmed splicing at a cryptic upstream splice acceptor site, resulting in the inclusion of 22 intronic bases. This extension results in a frameshift and a premature stop of translation (p.Gly1149Valfs*9). Segregation analysis revealed that three affected maternal cousins were homozygous for the intronic splice site variant. Our data show causality of both alterations and strongly suggest the expansion of the diagnostic strategy to search for intronic splice variants in molecularly unconfirmed patients affected by CS.Entities:
Keywords: COH1; Cohen syndrome; Compound heterozygous mutation; Copy number variation; Splice site mutation; VPS13B; WES
Year: 2020 PMID: 32505691 DOI: 10.1016/j.ejmg.2020.103973
Source DB: PubMed Journal: Eur J Med Genet ISSN: 1769-7212 Impact factor: 2.708